Ranked #3,799 of 8,699 institutional investors
Blue Owl Capital Holdings LP
New York, NY
$458M
US stock portfolio at live prices · today −$17.5M (−3.68%)
Live prices, last trade 12:25 PM ET
- Value at quarter end (Q3 2026)
- $546M
- Change from Q2 2026
- −$111.8M (−16.99%)
- Positions
- 50 · 13 new, 11 sold out
- Filed
- Nov 13, 2026
Not counted in the ranking: call options on $1.4M of stock. $7.8M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesSPCX 25.9%AKTS 11.9%LTGO 10.2%LRMR 6.57%NCDL 5.27%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| SPCX Space Exploration Technologies Corp. | 923,218 | $119M | 25.9% | Reduced −34% |
| AKTS Aktis Oncology, Inc. | 3,343,827 | $54.4M | 11.9% | Added +9% |
| LTGO Latigo Biotherapeutics, Inc. | 3,596,780 | $47.0M | 10.2% | New |
| LRMR Larimar Therapeutics, Inc. | 9,923,904 | $30.1M | 6.57% | Added +8% |
| NCDL Nuveen Churchill Direct Lending Corp. | 2,143,626 | $24.2M | 5.27% | Unchanged |
| ETRA Electra Therapeutics, Inc. | 2,611,143 | $22.3M | 4.87% | New |
| OBDC Blue Owl Capital Corporation | 2,045,070 | $21.9M | 4.77% | Unchanged |
| OBX Obsidian Therapeutics, Inc. | 1,482,767 | $17.7M | 3.86% | New |
| CGEM Cullinan Therapeutics, Inc. | 1,399,899 | $12.6M | 2.75% | Reduced −9% |
| HLLY Holley Inc. | 4,376,888 | $10.4M | 2.27% | Unchanged |
| SGMT Sagimet Biosciences Inc. | 1,125,544 | $10.1M | 2.21% | Reduced −11% |
| DELL Dell Technologies Inc. | 19,342 | $5.4M | 1.18% | Reduced −41% |
| MANE Veradermics Inc | 45,000 | $5.4M | 1.18% | New |
| AQST Aquestive Therapeutics, Inc. | 1,390,632 | $4.9M | 1.07% | Added +47% |
| CNDT Conduent Incorporated | 5,036,595 | $4.7M | 1.03% | Unchanged |
| PCOR Procore Technologies, Inc. | 64,030 | $4.7M | 1.02% | New |
| IMA ImageneBio, Inc. | 1,135,081 | $4.3M | 0.94% | Added +24% |
| IMMX Immix Biopharma, Inc. | 602,047 | $4.3M | 0.93% | Added +38% |
| FISN Deep Fission, Inc. | 1,333,333 | $4.1M | 0.90% | Unchanged |
| IRD Opus Genetics, Inc. | 969,605 | $3.8M | 0.83% | New |
| RZLT Rezolute, Inc. | 935,000 | $3.7M | 0.81% | New |
| CRVS Corvus Pharmaceuticals, Inc. | 358,600 | $3.5M | 0.76% | Reduced −41% |
| MPLT MapLight Therapeutics, Inc. | 556,371 | $3.4M | 0.75% | Reduced −24% |
| PVLA Palvella Therapeutics, Inc. | 23,003 | $3.4M | 0.74% | Reduced −37% |
| VRDN Viridian Therapeutics, Inc. | 100,000 | $3.1M | 0.67% | Reduced −62% |
| QUIT Achieve Life Sciences, Inc. | 412,654 | $2.4M | 0.52% | New |
| LENZ LENZ Therapeutics, Inc. | 781,722 | $2.4M | 0.52% | Added +3% |
| NTSK Netskope, Inc. | 97,148 | $2.3M | 0.50% | New |
| STWD Starwood Property Trust, Inc. | 196,355 | $2.2M | 0.47% | Unchanged |
| CMPX Compass Therapeutics, Inc. | 3,154,076 | $2.1M | 0.46% | Reduced −13% |
| ARTV Artiva Biotherapeutics, Inc. | 529,542 | $2.0M | 0.44% | Reduced −39% |
| TTAN ServiceTitan, Inc. | 25,360 | $2.0M | 0.43% | New |
| FA First Advantage Corporation | 88,665 | $1.9M | 0.41% | New |
| PYXS Pyxis Oncology, Inc. | 1,000,000 | $1.9M | 0.41% | New |
| ELDN Eledon Pharmaceuticals, Inc. | 566,509 | $1.0M | 0.22% | Unchanged |
| MRKR Marker Therapeutics, Inc. | 554,250 | $646K | 0.14% | Unchanged |
| WW WW International, Inc. | 71,277 | $506K | 0.11% | Reduced −16% |
| FLD Fold Holdings, Inc. | 856,632 | $257K | <0.1% | Unchanged |
| USDEW StablecoinX Inc. | 167,795 | $213K | <0.1% | Reduced −33% |
| PIPR Piper Sandler Companies | 2,428 | $149K | <0.1% | Unchanged |
| ET Energy Transfer LP | 5,326 | $100K | <0.1% | Unchanged |
| ENGNW enGene Therapeutics Inc. | 511,177 | $98K | <0.1% | Unchanged |
| NIOBW NioCorp Developments Ltd. | 268,280 | $91K | <0.1% | Unchanged |
| CAI Caris Life Sciences, Inc. | 4,711 | $84K | <0.1% | Unchanged |
| VOD Vodafone Group Public Limited Company | 5,371 | $76K | <0.1% | Unchanged |
| GLUE Monte Rosa Therapeutics, Inc. | 2,392 | $21K | <0.1% | New |
| KPLT Katapult Holdings, Inc. | 812 | $7K | <0.1% | Reduced −0% |
| AEON AEON Biopharma, Inc. | 42,353 | $5K | <0.1% | Unchanged |
| TVGNW Tevogen Inc. | 200,000 | $4K | <0.1% | Unchanged |
| DAVEW Dave Inc. | 28,750 | $2K | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| COF Capital One Financial Corporation | 119,757 | $21.7M |
| RYTM Rhythm Pharmaceuticals, Inc. | 61,455 | $6.9M |
| CMPS COMPASS Pathways plc | 450,000 | $3.6M |
| RARE Ultragenyx Pharmaceutical Inc. | 182,638 | $3.0M |
| ORIC ORIC Pharmaceuticals, Inc. | 400,000 | $3.0M |
| CHYM Chime Financial, Inc. | 89,878 | $2.7M |
| EVMN Evommune Inc | 180,000 | $1.3M |
| CABA Cabaletta Bio, Inc. | 714,710 | $689K |
| CNTX Context Therapeutics Inc. | 2,934,015 | $498K |
| EYPT EyePoint, Inc. | 762,594 | $187K |
| CELC Celcuity Inc. | 1,249 | $68K |